Technology News and Research

RSS

ChromoCure's new Southeast Research Center to be based in Aventura, Florida

ChromoCure, Inc. announced today its new Southeast Research Center to be based in Aventura, Florida.

17 Dec 2009

Phase Forward’s InForm Global Trial Management solution standardized to support early-stage clinical trials

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK’s Drug Development Office – the drug development arm of the world’s largest independent organization dedicated to cancer research – is standardizing on Phase Forward’s InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials.

17 Dec 2009

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

Arizona State University and Mayo Clinic in Arizona are joining forces in a partnership to investigate metabolic syndrome - a cluster of high-risk medical factors that include increased blood pressure, elevated insulin levels, excess body fat and abnormal cholesterol levels, which can lead to heart disease, stroke and diabetes.

16 Dec 2009

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

GlaxoSmithKline plc and NanoBio Corporation today announced an exclusive licensing agreement in the United States and Canada for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of cold sores. Developed by NanoBio, NB-001 provides significant antimicrobial activity against the virus that causes cold sores, herpes labialis.

16 Dec 2009

Makefield Therapeutics to patent applications covering its Hybrid Nanoparticle drug delivery platform

Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield's biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.

16 Dec 2009

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today that the Company received a milestone payment from Pfizer Inc. The amount of the payment was not disclosed. The payment was triggered by the initiation of human clinical trials of a novel monoclonal antibody therapeutic that was optimized using Xencor technologies under a March 2009 technology license agreement.

16 Dec 2009

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has signed a three-year single source provider contract with Novation, the industry's leading supply contracting company, for MAQUET's market-leading VASOVIEW Endoscopic Vessel Harvesting (EVH) Systems.

16 Dec 2009

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

During the 5th International Congress of Corneal Cross Linking for Keratoconus in Leipzig, Germany on December 5th, Avedro presented encouraging early clinical results for treating keratoconus, a progressive disease of the cornea of the eye. The procedure, known as Keraflex® KXL, is non-incisional and reshapes the cornea without removing any tissue.

16 Dec 2009

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

State government leaders, Medicaid agencies, hospital and physician associations, and other entities are formulating strategies for tapping federal stimulus money to create interoperable health information exchanges (HIEs).

16 Dec 2009

3M to supply and distribute TSO3's STERIZONE 125L+ Sterilizer

TSO3 Inc. and 3M (MMM) today announced that an agreement has been reached for 3M to be the exclusive supplier and distributor of TSO3's STERIZONE(R) 125L+ Sterilizer. The partnership with TSO3, an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, will include new cycles to reach acute care facilities through 3M's global sales channel.

16 Dec 2009

HealthInsight and HealthMedia join to deliver Internet-based Digital Coaching solutions

HealthInsight, provider of the only value-based health care administration platform, today announced a partnership with HealthMedia, Inc., a Johnson & Johnson company, to deliver Internet-based Digital Coaching™ solutions focused on lifestyle and behavioral change.

16 Dec 2009

EU border security market boosted by unauthorised immigration and illegal drug trafficking

European Union (EU) member states are spending more on protecting their borders, which are increasingly subjected to unauthorised immigration and illegal drug trafficking. High investment in advanced technology security and IT-based systems will boost the border security market.

16 Dec 2009

Eppendorf initiates import ban against Nanosphere's Verigene and Verigene SP systems

Eppendorf has initiated an import ban for Nanosphere, Inc.'s Verigene(R) and Verigene(R) SP systems for infringement of European patent EP 1 179 180 B2, titled "Method for the identification and/or the quantification of a target compound". The import ban covers any and all imports of the respective products into any country of the European Union. Customs authorities are required to confiscate any violating products.

16 Dec 2009

Food and Health Bureau invites EOI from Hong Kong in developing private hospitals

The Food and Health Bureau has invited expressions of interest (EOI) from Hong Kong and overseas parties in developing private hospitals at four sites in the Hong Kong Special Administrative Region.

16 Dec 2009

StemCells receives U.S. patent for propagation and/or derivation of embryonic stem cells

StemCells, Inc. announced today that it has received a Notice of Allowance and a Notice of Issuance from the U.S. Patent and Trademark Office for two patents claiming technologies for the establishment and maintenance of cell pluripotency (the ability to become any cell in the body, which is the defining attribute of embryonic stem cells), including the reprogramming of cells to create pluripotent stem cells.

16 Dec 2009

EIS Action-Units to collate and disseminate life-saving information to disaster-hit populations

Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.

16 Dec 2009

Modulating PN aggregase pathway may offer hope for Alzheimer’s disease

Proteostasis Therapeutics announced today that modulating a key Proteostasis Network (PN) pathway may offer a novel approach to Alzheimer’s disease, a finding that was published in the journal Cell by its scientific founders Andrew Dillin, Ph.D., and Jeffery Kelly, Ph.D. The publication describes how regulation of an aggregase pathway reduced the neurodegenerative effects of beta amyloid aggregates that are a hallmark of the disease.

16 Dec 2009

Biotage expands direct sales coverage

Biotage is expanding its direct sales coverage and will begin selling SPE products directly into non-pharma application areas within the UK starting January 18, 2010. Sales to non-pharmaceutical based markets and customers have previously been managed by a distributor.

16 Dec 2009

ProtoKinetix evaluates major European proposals to expand AAGP technology use

ProtoKinetix Inc. (PKTX) has been approached by a European biopharma investment group with a series of proposals to develop commercial partnerships in the pharmaceutical/cosmetic arenas.

16 Dec 2009

imaGenes achieves Roche NimbleGen CSP-status for ChIP-chip application

Roche NimbleGen has announced that imaGenes GmbH, a Berlin-based genomics & proteomics specialist, has achieved status as a Certified Service Provider (CSP) of NimbleGen microarrays for Chromatin Immunoprecipitation (ChIP-chip). imaGenes GmbH has passed a rigorous ChIP-chip certification to officially become part of the Roche NimbleGen Certified Service Provider Program.

16 Dec 2009

Technology News and Research

ChromoCure's new Southeast Research Center to be based in Aventura, Florida

Phase Forward’s InForm Global Trial Management solution standardized to support early-stage clinical trials

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

Makefield Therapeutics to patent applications covering its Hybrid Nanoparticle drug delivery platform

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

3M to supply and distribute TSO3's STERIZONE 125L+ Sterilizer

HealthInsight and HealthMedia join to deliver Internet-based Digital Coaching solutions

EU border security market boosted by unauthorised immigration and illegal drug trafficking

Eppendorf initiates import ban against Nanosphere's Verigene and Verigene SP systems

Food and Health Bureau invites EOI from Hong Kong in developing private hospitals

StemCells receives U.S. patent for propagation and/or derivation of embryonic stem cells

EIS Action-Units to collate and disseminate life-saving information to disaster-hit populations

Modulating PN aggregase pathway may offer hope for Alzheimer’s disease

Biotage expands direct sales coverage

ProtoKinetix evaluates major European proposals to expand AAGP technology use

imaGenes achieves Roche NimbleGen CSP-status for ChIP-chip application

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News